State Street’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.2K | Hold |
23,515
| – | – | ﹤0.01% | 4079 |
|
|
2025
Q1 | $68K | Hold |
23,515
| – | – | ﹤0.01% | 4044 |
|
|
2024
Q4 | $73.4K | Hold |
23,515
| – | – | ﹤0.01% | 4058 |
|
|
2024
Q3 | $76.2K | Sell |
23,515
-3
| -0% | -$10 | ﹤0.01% | 4030 |
|
|
2024
Q2 | $94.9K | Buy |
23,518
+2,875
| +14% | +$11.6K | ﹤0.01% | 4026 |
|
|
2024
Q1 | $121K | Hold |
20,643
| – | – | ﹤0.01% | 3995 |
|
|
2023
Q4 | $76.5K | Hold |
20,643
| – | – | ﹤0.01% | 4108 |
|
|
2023
Q3 | $114K | Hold |
20,643
| – | – | ﹤0.01% | 4079 |
|
|
2023
Q2 | $225K | Hold |
20,643
| – | – | ﹤0.01% | 3969 |
|
|
2023
Q1 | $258K | Buy |
20,643
+1,800
| +10% | +$22.5K | ﹤0.01% | 3970 |
|
|
2022
Q4 | $188K | Hold |
18,843
| – | – | ﹤0.01% | 4131 |
|
|
2022
Q3 | $226K | Buy |
18,843
+300
| +2% | +$3.6K | ﹤0.01% | 4086 |
|
|
2022
Q2 | $274K | Buy |
18,543
+3,642
| +24% | +$53.8K | ﹤0.01% | 4073 |
|
|
2022
Q1 | $266K | Buy |
14,901
+1,457
| +11% | +$26K | ﹤0.01% | 4283 |
|
|
2021
Q4 | $323K | Hold |
13,444
| – | – | ﹤0.01% | 4163 |
|
|
2021
Q3 | $269K | Buy |
13,444
+8,225
| +158% | +$165K | ﹤0.01% | 4242 |
|
|
2021
Q2 | $118K | Buy |
+5,219
| New | +$118K | ﹤0.01% | 4328 |
|
|
2017
Q3 | – | Sell |
-744
| Closed | -$39K | – | 3763 |
|
|
2017
Q2 | $39K | Hold |
744
| – | – | ﹤0.01% | 3611 |
|
|
2017
Q1 | $73K | Buy |
+744
| New | +$73K | ﹤0.01% | 3554 |
|